Literature DB >> 32651558

Frequency of alcohol drinking modifies the association between salt intake and albuminuria: a 1-year observational study.

Ryuichi Yoshimura1,2, Ryohei Yamamoto3,4,5, Maki Shinzawa1, Ryohei Tomi1, Shingo Ozaki1, Yoshiyuki Fujii1, Takafumi Ito2, Kazuaki Tanabe6, Yasuaki Moriguchi7, Yoshitaka Isaka1, Toshiki Moriyama1,8,9.   

Abstract

Albuminuria is an important risk factor for end-stage kidney disease and cardiovascular mortality. This 1-year observational study aimed to assess the effect modification of alcohol drinking on the association between salt intake and albuminuria. Overall, 448 employees at a pharmaceutical company in Japan who underwent annual health checkups in both 2017 and 2018 were evaluated. The main exposure of interest was drinking frequency at their first checkups categorized as rarely, occasionally, and daily. To assess the association between the changes in salt intake and albuminuria, the differences in salt intake estimated from single-spot urine specimens and the urinary albumin-to-creatinine ratio (UACR) between 2017 and 2018 were calculated for each subject. A multivariable-adjusted linear regression model showed a significant association between ∆salt intake and ∆Log UACR (per 1 g/day of ∆salt intake, adjusted ß 0.16 [95% confidence interval 0.14, 0.19]) and an effect modification between drinking frequency and ∆salt intake (P for interaction = 0.088). The association between ∆salt intake and ∆Log UACR was enhanced by drinking frequency in a dose-dependent manner (per 1 g/day of ∆salt intake, adjusted ß 0.13 [0.06, 0.19], 0.16 [0.12, 0.20], and 0.20 [0.13, 0.27] in rare, occasional, and daily drinkers, respectively). In conclusion, the results of the present study indicated that salt-induced albuminuria was enhanced in subjects with higher drinking frequency, suggesting that salt restriction may have a stronger renoprotective effect in subjects with higher drinking frequency.

Entities:  

Keywords:  Albuminuria; Alcohol drinking; Salt intake

Year:  2020        PMID: 32651558     DOI: 10.1038/s41440-020-0503-4

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  40 in total

1.  Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data.

Authors:  Kunihiro Matsushita; Shoshana H Ballew; Josef Coresh; Hisatomi Arima; Johan Ärnlöv; Massimo Cirillo; Natalie Ebert; Jade S Hiramoto; Heejin Kimm; Michael G Shlipak; Frank L J Visseren; Ron T Gansevoort; Csaba P Kovesdy; Varda Shalev; Mark Woodward; Florian Kronenberg
Journal:  Lancet Diabetes Endocrinol       Date:  2017-07-14       Impact factor: 32.069

2.  Urinary albumin excretion as a predictor of the development of hypertension in the general population.

Authors:  Auke H Brantsma; Stephan J L Bakker; Dick de Zeeuw; Paul E de Jong; Ronald T Gansevoort
Journal:  J Am Soc Nephrol       Date:  2006-02       Impact factor: 10.121

3.  High-normal albuminuria is strongly associated with incident chronic kidney disease in a nondiabetic population with normal range of albuminuria and normal kidney function.

Authors:  Aiko Okubo; Ayumu Nakashima; Shigehiro Doi; Toshiki Doi; Toshinori Ueno; Kazuya Maeda; Ryo Tamura; Kiminori Yamane; Takao Masaki
Journal:  Clin Exp Nephrol       Date:  2020-02-19       Impact factor: 2.801

4.  Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality.

Authors:  Juan Jesús Carrero; Morgan E Grams; Yingying Sang; Johan Ärnlöv; Alessandro Gasparini; Kunihiro Matsushita; Abdul R Qureshi; Marie Evans; Peter Barany; Bengt Lindholm; Shoshana H Ballew; Andrew S Levey; Ron T Gansevoort; Carl G Elinder; Josef Coresh
Journal:  Kidney Int       Date:  2016-12-04       Impact factor: 10.612

5.  Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.

Authors:  Kunihiro Matsushita; Marije van der Velde; Brad C Astor; Mark Woodward; Andrew S Levey; Paul E de Jong; Josef Coresh; Ron T Gansevoort
Journal:  Lancet       Date:  2010-05-17       Impact factor: 79.321

6.  High-normal albuminuria and incident chronic kidney disease in a male nondiabetic population.

Authors:  Aki Ashitani; Toshinori Ueno; Ayumu Nakashima; Shigehiro Doi; Kiminori Yamane; Takao Masaki
Journal:  Clin Exp Nephrol       Date:  2017-12-26       Impact factor: 2.801

7.  Urinary albumin excretion is a risk factor for diabetes mellitus in men, independently of initial metabolic profile and development of insulin resistance. The DESIR Study.

Authors:  Jean-Michel Halimi; Fabrice Bonnet; Céline Lange; Beverley Balkau; Jean Tichet; Michel Marre
Journal:  J Hypertens       Date:  2008-11       Impact factor: 4.844

8.  Albuminuria is an independent predictor of all-cause and cardiovascular mortality in the Japanese population: the Takahata study.

Authors:  Tsuneo Konta; Kosuke Kudo; Hiroko Sato; Kazunobu Ichikawa; Ami Ikeda; Kazuko Suzuki; Atsushi Hirayama; Yoko Shibata; Tetsu Watanabe; Makoto Daimon; Takeo Kato; Yoshiyuki Ueno; Takamasa Kayama; Isao Kubota
Journal:  Clin Exp Nephrol       Date:  2013-01-24       Impact factor: 2.801

9.  Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data.

Authors:  Kunihiro Matsushita; Josef Coresh; Yingying Sang; John Chalmers; Caroline Fox; Eliseo Guallar; Tazeen Jafar; Simerjot K Jassal; Gijs W D Landman; Paul Muntner; Paul Roderick; Toshimi Sairenchi; Ben Schöttker; Anoop Shankar; Michael Shlipak; Marcello Tonelli; Jonathan Townend; Arjan van Zuilen; Kazumasa Yamagishi; Kentaro Yamashita; Ron Gansevoort; Mark Sarnak; David G Warnock; Mark Woodward; Johan Ärnlöv
Journal:  Lancet Diabetes Endocrinol       Date:  2015-05-28       Impact factor: 32.069

10.  Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study.

Authors:  Daijo Inaguma; Enyu Imai; Ayano Takeuchi; Yasuo Ohashi; Tsuyoshi Watanabe; Kosaku Nitta; Tadao Akizawa; Seiichi Matsuo; Hirofumi Makino; Akira Hishida
Journal:  Clin Exp Nephrol       Date:  2016-07-13       Impact factor: 2.801

View more
  3 in total

Review 1.  The World Hypertension League Science of Salt: a regularly updated systematic review of salt and health outcomes studies (Sept 2019 to Dec 2020).

Authors:  Nan Xin Wang; JoAnne Arcand; Norm R C Campbell; Claire Johnson; Daniela Malta; Kristina Petersen; Sarah Rae; Joseph Alvin Santos; Bridve Sivakumar; Sudhir Raj Thout; Rachael McLean
Journal:  J Hum Hypertens       Date:  2022-06-10       Impact factor: 3.012

Review 2.  Annual reports on hypertension research 2020.

Authors:  Masaki Mogi; Yukihito Higashi; Kanako Bokuda; Atsuhiro Ichihara; Daisuke Nagata; Atsushi Tanaka; Koichi Node; Yoichi Nozato; Koichi Yamamoto; Ken Sugimoto; Hirotaka Shibata; Satoshi Hoshide; Hitoshi Nishizawa; Kazuomi Kario
Journal:  Hypertens Res       Date:  2021-10-15       Impact factor: 3.872

3.  Hypertension, cardiovascular disease, and nocturia: a systematic review of the pathophysiological mechanisms.

Authors:  Mitsuru Ohishi; Takuro Kubozono; Koji Higuchi; Yuichi Akasaki
Journal:  Hypertens Res       Date:  2021-03-03       Impact factor: 3.872

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.